Characteristics | Variable | Concordance NÂ =Â 121 | Discordance NÂ =Â 167 | Adjusted odds ratio | |||
---|---|---|---|---|---|---|---|
N (%) | 95% CI | N (%) | 95% CI | (95% CI) | p value | ||
Sex | Male | 62 (29%) | 23–35 | 154 (71%) | 65–77 | 1 |  |
Female | 59 (82%) | 71–90 | 13 (18%) | 10–29 | 4.8 (2.0–11.4) | <0.001 | |
Education | Secondary or less | 56 (40%) | 32–49 | 84 (60%) | 51–68 | 1 |  |
High school | 45 (39%) | 30–48 | 71 (61%) | 52–70 | 1.2 (0.6–2.3) | NS | |
College/university | 20 (63%) | 44–78 | 12 (37%) | 22–56 | 3.2 (1.2–8.7) | 0.025 | |
Occupation | Unemployed | 14 (27%) | 16–41 | 38 (73%) | 59–84 | 0.8 (0.3–1.9) | NS |
Employed | 107 (45%) | 39–52 | 129 (55%) | 48–61 | 1 |  | |
Having children | Yes | 89 (40%) | 34–47 | 132 (60%) | 53–66 | 1 |  |
No | 32 (48%) | 36–60 | 35 (52%) | 40–64 | 1.3 (0.6–2.7) | NS | |
Resident’s area | Dong Trieu | 25 (68%) | 50–81 | 12 (32%) | 19–49 | 5.2 (1.7–15.4) | 0.003 |
Uong Bi | 20 (47%) | 31–62 | 23 (53%) | 38–69 | 2.5 (0.997–6.5) | 0.051 | |
Yen Hung | 16 (46%) | 29–63 | 19 (54%) | 37–71 | 2.4 (0.9–6.8) | NS | |
Ha Long | 60 (35%) | 28–42 | 113 (65%) | 58–72 | 1 |  | |
Mode of HIV infection | Sexual intercourse | 85 (60%) | 51–68 | 57 (40%) | 32–48 | 1 |  |
IDU | 26 (21%) | 14–29 | 100 (79%) | 71–86 | 0.4 (0.2–1.1) | NS | |
Do not know | 10 (42%) | 23–63 | 14 (58%) | 37–77 | 0.6 (0.2–2.0) | NS | |
Hepatitis coinfection | Yes | 29 (32%) | 23–42 | 62 (68%) | 54–77 | 0.6 (0.3–1.3) | NS |
No | 92 (47%) | 40–54 | 105 (53%) | 46–60 | 1 |  | |
History of IDU | Yes | 31 (22%) | 16–30 | 109 (78%) | 70–84 | 0.6 (0.3–1.3) | NS |
No | 90 (61%) | 52–69 | 58 (39%) | 31–48 | 1 |  | |
Clinical stage | Stage 3 or 4 | 68 (49%) | 40–57 | 71 (51%) | 43–59 | 1 |  |
Stage 1 or 2 | 53 (36%) | 28–44 | 96 (64%) | 56–72 | 0.9 (0.4–1.7) | NS | |
Duration of known HIV infection | ≥2 years | 80 (46%) | 39–54 | 93 (54%) | 46–61 | 1 | NS |
<2 year | 41 (36%) | 27–45 | 74 (64%) | 55–73 | 0.6 (0.3–1.3) | NS | |
History of TB | Yes | 10 (25%) | 13–41 | 30 (75%) | 58–87 | 1 |  |
No | 111 (45%) | 39–51 | 137 (55%) | 49–61 | 0.2 (0.05–0.8) | 0.026 | |
CD4 cell count | ≥100/µl | 73 (52%) | 43–60 | 68 (48%) | 40–57 | 1 |  |
<100/µl | 48 (33%) | 25–41 | 99 (67%) | 59–75 | 1.1 (0.6–2.2) | NS | |
Viral load | ≥100,000 copies/ml | 40 (39%) | 29–49 | 63 (61%) | 51–70 | 1.1 (0.5–2.1) | NS |
<100,000 copies/ml | 81 (44%) | 37–51 | 104 (56%) | 49–63 | 1 |  |